Article metrics

Download PDFPDF

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

 

Online download statistics by month:

Online download statistics by month: February 2019 to August 2020

AbstractFullPdf
Feb 201914281413127
Mar 201923222753
Apr 201913212928
May 201911310637
Jun 2019565022
Jul 2019434119
Aug 20191754714
Sep 2019144357
Oct 20191544019
Nov 20191733917
Dec 20191904210
Jan 20202525520
Feb 202032213726
Mar 202022611430
Apr 20202075528
May 20201323620
Jun 2020625445
Jul 2020564417
Aug 2020995
Total41062673544